# EDWARDS LIFESCIENCES CORPORATION (EW) FY2025 Q1 Balance Sheet

- Company: EDWARDS LIFESCIENCES CORPORATION (EW)
- Period: As of 2025-03-31
- Filing: Q1 FY2025 10-Q, filed 2025-05-06, accession number 0001099800-25-000023
- Page: https://plicit.ai/financials/ew/fy2025-q1-balance-sheet
- Chart image: https://plicit.ai/charts/ew-fy2025-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2025-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 13,022,300,000 US dollars
- **Current assets**: 6,212,700,000 US dollars
- **Non-current assets**: 6,809,600,000 US dollars
- **Liabilities**: 2,830,700,000 US dollars
- **Current liabilities**: 1,394,800,000 US dollars
- **Non-current liabilities**: 1,435,900,000 US dollars
- **Equity**: 10,191,600,000 US dollars
- **Noncontrolling interest**: 62,900,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Cash and cash equivalents**: 3,140,600,000 US dollars
- **Inventories (Note 2)**: 1,113,900,000 US dollars
- **Short-term investments (Note 5)**: 757,900,000 US dollars
- **Accounts receivable, net of allowances of $12.6 and $11.6, respectively**: 669,200,000 US dollars
- **Other current assets**: 304,500,000 US dollars
- **Prepaid expenses**: 111,300,000 US dollars
- **Other receivables**: 82,700,000 US dollars
- **Current assets of discontinued operations (Note 4)**: 32,600,000 US dollars
- **Goodwill**: 1,778,700,000 US dollars
- **Property, plant, and equipment, net**: 1,698,300,000 US dollars
- **Other intangible assets, net**: 1,174,900,000 US dollars
- **Deferred income taxes**: 1,027,800,000 US dollars
- **Other assets (Note 2)**: 742,700,000 US dollars
- **Long-term investments (Note 5)**: 277,900,000 US dollars
- **Operating lease right-of-use assets**: 96,900,000 US dollars
- **Non-current assets of discontinued operations (Note 4)**: 12,400,000 US dollars
- **Accrued and other liabilities (Note 2)**: 1,196,400,000 US dollars
- **Accounts payable**: 172,400,000 US dollars
- **Operating lease liabilities**: 23,700,000 US dollars
- **Current liabilities of discontinued operations (Note 4)**: 2,300,000 US dollars
- **Long-term debt**: 597,800,000 US dollars
- **Uncertain tax positions**: 402,600,000 US dollars
- **Other liabilities**: 357,600,000 US dollars
- **Operating lease liabilities**: 77,900,000 US dollars
- **Retained earnings**: 13,525,000,000 US dollars
- **Additional paid-in capital**: 2,653,200,000 US dollars
- **Common stock, $1.00 par value, 1,050.0 shares authorized, 655.9 and 654.8 shares issued, and 586.2 and 588.6 shares outstanding, respectively**: 655,900,000 US dollars
- **Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding**: 0 US dollars
- **Noncontrolling interest**: 62,900,000 US dollars
- **Treasury stock, at cost, 69.7 and 66.2 shares, respectively**: negative 6,450,900,000 US dollars
- **Accumulated other comprehensive loss (Note 12)**: negative 254,500,000 US dollars
- **Gross equity (calculated)**: 16,897,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.